Neutrophil gelatinase-associated lipocalin (NGAL) is used as an early biomarker of renal
injury in people. In dogs, increases in urinary NGAL (uNGAL) precede increases in serum …

Background Neutrophil gelatinase–associated lipocalin (NGAL) is released from renal
tubular cells after injury and serves in humans as a real‐time indicator of active kidney …

Background Acute kidney injury (AKI) is a common and often fatal disorder in dogs.
Hypothesis Urine neutrophil gelatinase‐associated lipocalin (NGAL)/creatinine ratio is a …

Background Biomarkers for the early prediction of canine acute kidney injury (AKI) are
clinically important. Recently, neutrophil gelatinase-associated lipocalin (NGAL) was found …

Background Urine neutrophil gelatinase‐associated lipocalin (NGAL) is a promising
biomarker of acute kidney injury (AKI) in dogs. Objectives To evaluate the utility of urinary …

Background Neutrophil gelatinase–associated lipocalin (NGAL) is a protein that is used in
human medicine as a real‐time indicator of acute kidney injury (AKI). Hypothesis Dogs with …

Background Active kidney injury may play a role in chronic kidney disease (CKD)
progression in dogs. Neutrophil gelatinase‐associated lipocalin (NGAL), a novel tubular …

Background Acute kidney injury (AKI) is associated with high mortality rates in dogs, which
may be a consequence of late recognition using traditional diagnostic tests. Neutrophil …

Background Neutrophil gelatinase‐associated lipocalin (NGAL) has been shown to be a
useful marker of kidney injury in people and dogs, but has not been described in horses …

Background Neutrophil gelatinase‐associated lipocalin (NGAL) is a biomarker for the early
prediction of renal damage and the progression of chronic kidney disease (CKD) in humans …